SOLAREDGE TECHNOLOGIES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SOLAREDGE TECHNOLOGIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $901.46M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $2.98B | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $3.11B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.96B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.46B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $1.43B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $937.24M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $607.05M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $240.00M | Feb 28, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $607.05M | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $240.00M | Feb 20, 2018 |
| FY2017 | Jun 30, 2016 | $489.84M | Feb 20, 2018 |
| FY2017 | Jun 30, 2015 | $325.08M | Feb 20, 2018 |
| FY2016 | Jun 30, 2014 | $133.22M | Aug 17, 2016 |
| FY2015 | Jun 30, 2013 | $79.04M | Aug 20, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $196.28M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($877.20M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $703.82M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $844.65M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $629.32M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $461.36M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $479.34M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $319.24M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $214.77M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $80.90M | Feb 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($405.45M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.81B) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $34.33M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $441.73M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $169.17M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $140.32M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $146.55M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $128.83M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $84.17M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $25.38M | Feb 28, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($301.68M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.71B) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $40.21M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $166.12M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $207.14M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $142.56M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $189.95M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $139.42M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $91.09M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $33.39M | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $221.26M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $277.24M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $321.48M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $289.81M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $219.63M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $163.12M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $121.35M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $82.25M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $54.97M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $20.28M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.26M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($313.32M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | ($180.11M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $31.28M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $214.13M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $222.66M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $259.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $189.08M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $136.67M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $49.02M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.47M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $108.16M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $170.52M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $169.34M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $149.25M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $126.79M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $72.56M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $38.61M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $21.38M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $11.03M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18B | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.65B | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $4.59B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $4.27B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.90B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.44B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $964.47M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $641.31M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $424.74M | Feb 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $427.46M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $658.34M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $2.41B | Mar 23, 2026 |
| FY2025 | Dec 31, 2022 | $2.18B | Mar 23, 2026 |
| FY2024 | Dec 31, 2021 | $1.31B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $1.09B | Feb 26, 2024 |
| FY2022 | Dec 31, 2019 | $811.67M | Feb 22, 2023 |
| FY2020 | Dec 31, 2018 | $562.41M | Feb 19, 2021 |
| FY2020 | Dec 31, 2017 | $397.47M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $288.78M | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.12M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $48.38M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $43.00M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $31.19M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $129.63M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $140.48M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $129.65M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $34.87M | Feb 19, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.43B) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.03B) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $778.17M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $743.84M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $650.06M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $478.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $337.68M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $191.13M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $66.17M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | ($18.00M) | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $455.08M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $274.61M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $338.47M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $783.11M | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $530.09M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $827.15M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $223.90M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $187.76M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $163.16M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $104.68M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (6) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (6) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 28, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 60.36M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 58.03M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 57.12M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 56.13M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 52.82M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 51.56M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 48.90M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 46.05M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 43.81M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | 41.26M | Feb 28, 2019 |